QQ客服 官方微博 反馈留言

	TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells
	Jing Chen; Xiaobei Liu; Yichen Xu; Kai Zhang; Jiayuan Huang; Banzhou Pan; Dongqin Chen; Shiyun Cui; Haizhu Song; Rui Wang
刊名	Molecular Therapy - Nucleic Acids
	2019
卷号	Vol.14页码:567-582
关键词	MALAT1 miR-200b LUAD chemoresistance
ISSN号	2162-2531
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4617984
专题	湖南大学
作者单位	1.Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, China 2.Department of Respiratory, Zhongda Hospital, Southeast University, Nanjing, China 3.Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China 4.Department of Medical Oncology, Jiangsu Cancer Hospital Affiliated to Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu, China 5.Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University, Suzhou, Jiangsu, China
推荐引用方式 GB/T 7714	Jing Chen,Xiaobei Liu,Yichen Xu,et al. TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells[J]. Molecular Therapy - Nucleic Acids,2019,Vol.14:567-582.
APA	Jing Chen.,Xiaobei Liu.,Yichen Xu.,Kai Zhang.,Jiayuan Huang.,...&Longbang Chen.(2019).TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells.Molecular Therapy - Nucleic Acids,Vol.14,567-582.
MLA	Jing Chen,et al."TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells".Molecular Therapy - Nucleic Acids Vol.14(2019):567-582.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。